PeptideTreatments
Reviewed by Peptide Treatments Medical Advisory Board

Gonadorelin: Research & Evidence

Established Evidence

Published research, clinical trial data, and evidence grading for Gonadorelin across studied indications.

Back to Gonadorelin overview

Research Summary

Gonadorelin has a robust evidence base with 500+ human studies, 50+ RCTs, and multiple meta-analyses confirming its efficacy for pituitary diagnostics, hypogonadotropic hypogonadism treatment, and IVF protocols. FDA-approved since 1982 under brand names Factrel and Lutrepulse, it is considered standard of care for maintaining fertility in men on TRT and for controlled ovarian stimulation in assisted reproduction.

Evidence by Indication (4 indications)

Indication Tier Trials Summary
Pituitary diagnostic testing Tier A 50 FDA-approved 1982; gold standard for gonadotroph function assessment
Hypogonadotropic hypogonadism Tier A 30 80% response rate in Phase 3 trials; FDA-approved
IVF protocols Tier A 100 Standard of care with multiple meta-analyses
Fertility preservation on TRT Tier B 10 Moderate evidence; widely used off-label

Graded using our evidence tier methodology.

Research Gap Score /10

Higher score = larger gap between therapeutic potential and available clinical evidence.

Citations (10 sources)

  1. 1. Gonadorelin diagnostic test for pituitary function Study

    Multiple authors (1982), Journal of Clinical Endocrinology and Metabolism

  2. 2. Treatment of hypogonadotropic hypogonadism with pulsatile GnRH Study

    Multiple authors (1993), Journal of Clinical Endocrinology and Metabolism

  3. 3. GnRH protocols in IVF: systematic review Review

    Multiple authors (1999), Human Reproduction

  4. 4. GnRH therapy for cryptorchidism in children Study

    Multiple authors (1994), Pediatrics

  5. 5. GnRH agonists: gonadorelin, leuprolide and nafarelin. Study

    Pace JN, Miller JL, Rose LI (1991), American family physician

  6. 6. Gonadotropin-releasing hormone and its analogs. Study

    Conn PM, Crowley WF Jr (1994), Annual review of medicine

  7. 7. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Study

    Ishikawa T, Ooba T, Kondo Y, et al. (2007), Fertility and sterility

  8. 8. Gonadotrophin replacement for induction of fertility in hypogonadal men. Study

    Dwyer AA, Raivio T, Pitteloud N (2015), Best practice & research. Clinical endocrinology & metabolism

  9. 9. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. Study

    Miyagawa Y, Tsujimura A, Matsumiya K, et al. (2005), The Journal of urology

  10. 10. [The influence of arterial partial pressure of co2 and of the arterial value of ph on endogenous catecholamines during extracorporal circulation in regard to oxygen consumption of the whole body (author's transl)]. Study

    Schreiner-Hecheltjen J (1980), Der Anaesthesist